Given the precarious excitement of the moment—or is it exciting precarity?—policymakers and healthcare leaders must set directives guiding not only what to do with AI but also when to do it. 

The presentations will cover a variety of topics, including coronary artery disease, semaglutide, artificial intelligence, TAVR, heart failure, PCI and much more. ACC.25 takes place March 29-31 in Chicago.

Meril Life Sciences has been manufacturing its Myval heart valves for years. The devices are approved and available in both India and Europe, but they have not been approved by the FDA.

What is Stargate and why is it here? 

Integrating AI into the electronic medical record can make patient data more usable and dependable for end-users, according to a review of the relevant scientific literature published this month in the American Journal of Clinical and Medical Research.

It looked like the wildfires in Los Angeles could force STS to cancel its annual meeting, but the group worked with city officials and was able to carry on as planned. STS President Jennifer C. Romano, MD, MS, discussed that difficult decision and previewed the three-day event in a new interview.

HHS isn’t waiting to see what its incoming secretary does before filling some key leadership positions. 

When appropriately applied in critical care settings, AI can deliver considerable value to clinical staff, hospital management and local communities. In the process the technology may help resolve persistent staffing shortages.